A Co‐occurrence of Trinucleotide Repeat Disorders

Jason Margolesky(University of Miami), Carlos Singer(University of Miami Health System), Simon Starosta‐Rubenstein(Baptist Health South Florida), Ashok Verma(Government Medical College)

Movement Disorders Clinical Practice

August 12, 2018

10.1002/mdc3.12664

Cited by 1

Related Papers

Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease

|JAMA|2016|397

Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder

|Sleep Medicine|2013|391

Rapid eye movement sleep behavior disorder: devising controlled active treatment studies for symptomatic and neuroprotective therapy—a consensus statement from the International Rapid Eye Movement Sleep Behavior Disorder Study Group

|Sleep Medicine|2013|238

A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease

|Neurology|2016|137

Genotype–Phenotype Relations in Primary Familial Brain Calcification: Systematic <scp>MDSGene</scp> Review

|Movement Disorders|2021|93